Medtronic Sustainability Profile
Medtronic plc, a global leader in medical technology, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1949, the company has pioneered advancements in various medical fields, including cardiovascular, diabetes, and neurological care. Medtronic is renowned for its innovative core products, such as insulin pumps, cardiac devices, and surgical instruments, which are designed to improve patient outcomes and enhance quality of life. The company’s commitment to research and development has positioned it as a market leader, with notable achievements including the first successful implant of a cardiac pacemaker. With a strong focus on patient-centric solutions, Medtronic continues to set industry standards, making significant contributions to healthcare worldwide.
DitchCarbon Score
How does Medtronic's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medtronic's score of 50 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medtronic's reported carbon emissions
In 2023, Medtronic reported total greenhouse gas emissions of approximately 256,800,000 kg CO2e, comprising 131,500,000 kg CO2e from Scope 1 and 125,200,000 kg CO2e from Scope 2 emissions. The company has set ambitious targets to reduce its absolute Scope 1 and Scope 2 emissions by 52% by 2030, using a 2020 baseline. This commitment aligns with the Science Based Targets initiative (SBTi) and reflects Medtronic's dedication to climate action. For the year 2022, Medtronic's emissions in the US included 75,663,000 kg CO2e from Scope 1 and 98,627,000 kg CO2e from Scope 2. Globally, the company reported Scope 1 emissions of 94,904,000 kg CO2e and Scope 2 emissions of 189,802,000 kg CO2e, alongside significant Scope 3 emissions from business travel and transportation. Medtronic is also committed to sourcing 100% renewable electricity by 2030 and aims for 75% of its suppliers to have science-based targets by the same year. The company has pledged to reduce its absolute Scope 3 emissions by 37.5% by 2034, focusing on upstream transportation, business travel, and end-of-life treatment of sold products. Overall, Medtronic's climate commitments reflect a robust strategy to mitigate its carbon footprint and contribute to global climate goals, with a clear focus on transparency and accountability in its emissions reporting.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | - |
How Carbon Intensive is Medtronic's Industry?
How Carbon Intensive is Medtronic's Location?
Medtronic's Scope 3 Categories Breakdown
Medtronic's Scope 3 emissions, which increased by 48% last year and increased by approximately 48% since 2021, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 55% of total emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the largest emissions source at 47% of Scope 3 emissions.
Top Scope 3 Categories
Medtronic's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medtronic has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
C. R. Bard, Inc.
Frequently Asked Questions
Common questions about Medtronic's sustainability data and climate commitments